CD19 EXPRESSION DECREASED

This adverse event was reported 3 times

These drugs are most commonly taken by patients reporting CD19 EXPRESSION DECREASED:

# Drug Count
0 BLINATUMOMAB 1
1 FUROSEMIDE 1
2 LENALIDOMIDE 1
3 METOPROLOL 1
4 METOPROLOL TARTRATE 1
5 METOPROLOL TARTRATE INJECTION 1
6 PANTOPRAZOLE 1
7 ROSUVASTATIN 1
8 TAFASITAMAB-CXIX 1
See all common drugs associated with CD19 EXPRESSION DECREASED

CD19 EXPRESSION DECREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TAFASITAMAB-CXIX 1 0.0011
1 BLINATUMOMAB 1 0.0001
2 ROSUVASTATIN 1 0.0000
3 PANTOPRAZOLE 1 0.0000
4 METOPROLOL TARTRATE 1 0.0000
5 FUROSEMIDE 1 0.0000
6 LENALIDOMIDE 1 0.0000
See all drugs enriched for association with CD19 EXPRESSION DECREASED

These drug classes are most commonly taken by patients reporting CD19 EXPRESSION DECREASED:

# Drug class Count
0 CD20-directed Cytolytic Antibody [EPC] 1
1 HMG-CoA Reductase Inhibitor [EPC] 1
2 Loop Diuretic [EPC] 1
3 Thalidomide Analog [EPC] 1
See all common drug classes associated with CD19 EXPRESSION DECREASED

CD19 EXPRESSION DECREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
1 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
2 Loop Diuretic [EPC] 1 0.0000
3 Thalidomide Analog [EPC] 1 0.0000
See all drug classes enriched for association with CD19 EXPRESSION DECREASED